SCHEMBL25476901

SCHEMBL25476901

Cc1ccc(C(=O)Oc2cc(C)nn2C)c(S(C)(=O)=O)c1

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.36
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MAPT P10636 6/20 0.35
KMT2A Q03164 6/20 0.35
ALOX15 P16050 1/20 0.35
HTT P42858 2/20 0.33
TDP1 Q9NUW8 1/20 0.32
MAPK1 P28482 2/20 0.32
HSD17B10 Q99714 2/20 0.32
TSHR P16473 2/20 0.32
USP2 O75604 1/20 0.32
HPGD P15428 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
MEN1 O00255 2/20 0.32
NPSR1 Q6W5P4 1/20 0.32
SLC9A1 P19634 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10035230 0.85 MAPT (0.35) ALDH1A1ATML3MBTL1MAPTKMT2A
SCHEMBL29790347 0.85 ATM (0.40) ALDH1A1ATMHSD17B10USP2HPGD
SCHEMBL23236886 0.85 ATM (0.40) ALDH1A1ATMHSD17B10USP2HPGD
SCHEMBL11601679 0.83 NPC1 (0.41) ALDH1A1ATML3MBTL1MAPTKMT2A
SCHEMBL28388499 0.78 KMT2A (0.41) ALDH1A1MAPTKMT2AHTTTSHR
SCHEMBL28340599 0.78 KDM4E (0.40) ALDH1A1ALOX15HSD17B10
SCHEMBL23236815 0.77 MAPT (0.32) ALDH1A1MAPTKMT2AALOX15HTT
SCHEMBL22859717 0.77 MAPT (0.32) MAPTKMT2AALOX15HTTTSHR
SCHEMBL29790417 0.77 MAPT (0.32) ALDH1A1MAPTKMT2AALOX15HTT
SCHEMBL11653261 0.76 MAPT (0.50) ALDH1A1ATML3MBTL1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230157290-A1 ALKENE-CONTAINING CARBOXYLATE COMPOUND AND USE THEREOF JIANGSU YANGNONG CHEMICAL CO., LTD (CN) 2023-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230157290-A1 ALKENE-CONTAINING CARBOXYLATE COMPOUND AND USE THEREOF DDT, ALK, ACMSD ALDH1A1 33/4885ATM 3104/4885L3MBTL1 2089/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.